Literature DB >> 31776799

Diagnosis and Treatment of Breast Cancer in Young Women.

Lorenzo Rossi1,2, Calogero Mazzara3,4, Olivia Pagani3,4.   

Abstract

OPINION STATEMENT: Despite the increase of breast cancer incidence with age, approximately 7 to 10% ofwomen diagnosed with breast cancer are younger than the age 40. This subgroup ofpatients has different risk factors, tumour biology, clinical outcomes, and specific psy- chosocial issues, such as fertility preservation, family planning, and job reintegration. However, age alone should not be the main consideration when choosing the aggressive- ness of the treatment, as other factors must be considered, including the biologic aggressiveness of the tumour, potential long-term toxicities, and the preferences of the patient. Fertility preservation techniques should be discussed with the patient before starting any cancer treatment. Despite the significant percentage of breast cancer patients younger than age 40, fewclinical studies have specifically investigated disease characteristics and outcomes of this population, and most therapies routinely administered to these younger women were tested in older patients. Moreover, young women who have breast cancer are at a greater risk of sexual and psychological distress, and clinicians should address these issues in order to properly support patients during the long diagnostic and therapeutic journey. Consequently, it is essential to follow diagnostic and treatment guidelines specificallyaddressed to young women. Additional specific procedures should be followed to treat pregnant patients with breast cancer.

Entities:  

Keywords:  Breast cancer; Diagnosis; Fertility; Pregnancy; Treatment; Young women

Mesh:

Year:  2019        PMID: 31776799     DOI: 10.1007/s11864-019-0685-7

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  20 in total

1.  [Melatonin inhibits growth and metastasis of MDA-MB-231 breast cancer cells by activating autophagy].

Authors:  D Wu; Y Zhang; H Tang; J Yang; M Li; H Liu; Q Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

2.  Clinical features and prognostic factors of breast cancer in young women: a retrospective single-center study.

Authors:  Weigang Wang; Baoguo Tian; Xiaoqin Xu; Xiaofang Zhang; Yan Wang; Lili Du; Jiexian Jing
Journal:  Arch Gynecol Obstet       Date:  2022-07-15       Impact factor: 2.493

3.  A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy.

Authors:  Maria K Lagou; Dimitra P Anastasiadou; George S Karagiannis
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

4.  Effects of fentanyl and dexmedetomidine as adjuvants to bupivacaine in paravertebral block for postoperative analgesia in patients undergoing modified radical mastectomy: A prospective randomised double-blind study.

Authors:  Nibedita Pani; Padmalaya Sahu; Deepti Swain; Chetna Biswal; Amit Pradhan; Sidharth Sraban Routray
Journal:  Indian J Anaesth       Date:  2022-06-06

5.  Preoperative Nomogram for Predicting Sentinel Lymph Node Metastasis Risk in Breast Cancer: A Potential Application on Omitting Sentinel Lymph Node Biopsy.

Authors:  Xi'E Hu; Jingyi Xue; Shujia Peng; Ping Yang; Zhenyu Yang; Lin Yang; Yanming Dong; Lijuan Yuan; Ting Wang; Guoqiang Bao
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

6.  Establishment and Verification of Prognostic Nomograms for Young Women With Breast Cancer Bone Metastasis.

Authors:  Zhan Wang; Haiyu Shao; Qiang Xu; Yongguang Wang; Yaojing Ma; Diarra Mohamed Diaty; Jiahao Zhang; Zhaoming Ye
Journal:  Front Med (Lausanne)       Date:  2022-04-12

7.  Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer.

Authors:  Francesca Parisi; Maria Grazia Razeti; Eva Blondeaux; Luca Arecco; Marta Perachino; Marco Tagliamento; Alessia Levaggi; Piero Fregatti; Francesca Poggio; Matteo Lambertini
Journal:  Clin Med Insights Oncol       Date:  2020-06-29

8.  MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway.

Authors:  Jingyun Guo; Can Luo; Yuqin Yang; Jianyu Dong; Zhaoze Guo; Jinlamao Yang; Huining Lian; Changsheng Ye; Minfeng Liu
Journal:  Cancer Manag Res       Date:  2021-01-15       Impact factor: 3.989

9.  "Lights and Shadows": An Interpretative Phenomenological Analysis of the Lived Experience of Being Diagnosed With Breast Cancer During Pregnancy.

Authors:  Federica Facchin; Giovanna Scarfone; Giancarlo Tamanza; Silvia Ravani; Federica Francini; Fedro Alessandro Peccatori; Eugenia Di Loreto; Andrea Dell'Acqua; Emanuela Saita
Journal:  Front Psychol       Date:  2021-04-01

10.  Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors.

Authors:  Qi-Fang Liu; Zi-Yi Feng; Li-Li Jiang; Tong-Tong Xu; Si-Man Li; Kui-Ran Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.